GLAND

Gland Pharma Limited, established in Hyderabad, India in 1978, is a pharmaceutical company focused on the development, manufacturing, and marketing of complex generic injectable products. Operating primarily through a business-to-business model, the company offers contract development and manufacturing organization (CDMO) services alongside the out-licensing of its generic injectable portfolio. Its product range includes generic injectables and complex injectables such as oncology, ophthalmic, and biologic formulations. Gland Pharma serves markets including the United States, Europe, Canada, Australia, India, and other regions. In 2023, the company acquired Cenexi, a move that facilitated the expansion of its manufacturing capabilities into Europe. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major, and operates primarily within the pharmaceutical and injectable industries, with headquarters in Hyderabad.